Ausgabe 2/2012
Inhalt (11 Artikel)
Notch Regulation of Bone Development and Remodeling and Related Skeletal Disorders
Stefano Zanotti, Ernesto Canalis
Ectopic Expression of SOX9 in Osteoblasts Alters Bone Mechanical Properties
Bojian Liang, Meghan M. Cotter, Dongxing Chen, Christopher J. Hernandez, Guang Zhou
The Effect of Oral Glucose Tolerance Test on Serum Osteocalcin and Bone Turnover Markers in Young Adults
P. M. Paldánius, K. K. Ivaska, P. Hovi, S. Andersson, H. K. Väänänen, E. Kajantie, O. Mäkitie
A Polymorphism in a Gene Encoding Perilipin 4 Is Associated with Height but not with Bone Measures in Individuals from the Framingham Osteoporosis Study
Natalie E. Cusano, Douglas P. Kiel, Serkalem Demissie, David Karasik, L. Adrienne Cupples, Dolores Corella, Qiong Gao, Kris Richardson, Nikos Yiannakouris, Jose M. Ordovas
Longitudinal Assessment of In Vivo Bone Dynamics in a Mouse Tail Model of Postmenopausal Osteoporosis
Floor M. Lambers, Gisela Kuhn, Friederike A. Schulte, Kathleen Koch, Ralph Müller
Evaluation of Methylation Status of the eNOS Promoter at Birth in Relation to Childhood Bone Mineral Content
Nicholas C. Harvey, Karen A. Lillycrop, Emma Garratt, Allan Sheppard, Cameron McLean, Graham Burdge, Jo Slater-Jefferies, Joanne Rodford, Sarah Crozier, Hazel Inskip, Bright Starling Emerald, Catharine R. Gale, Mark Hanson, Peter Gluckman, Keith Godfrey, Cyrus Cooper
Absolute Fracture-Risk Prediction by a Combination of Calcaneal Quantitative Ultrasound and Bone Mineral Density
Mei Y. Chan, Nguyen D. Nguyen, Jacqueline R. Center, John A. Eisman, Tuan V. Nguyen
Genetic Polymorphisms of the Wnt Receptor LRP5 are Differentially Associated with Trochanteric and Cervical Hip Fractures
Javier Riancho, Carmen García-Ibarbia, María I. Pérez-Núñez, María A. Alonso, Teresa Díaz, José L. Pérez-Castrillón, José A. Riancho
Knee Arthroplasty and Risk of Hip Fracture: A Population-Based, Case–Control Study
Arief Lalmohamed, Frans Opdam, Nigel K. Arden, Daniel Prieto-Alhambra, Tjeerd van Staa, Hubertus G. M. Leufkens, Frank de Vries
A Class III Semaphorin (Sema3e) Inhibits Mouse Osteoblast Migration and Decreases Osteoclast Formation In Vitro
Alun Hughes, Jennifer Kleine-Albers, Miep H. Helfrich, Stuart H. Ralston, Michael J. Rogers
Antiosteoporotic Drugs and Incidence of Type 2 Diabetes Mellitus
Ippei Kanazawa